Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03550118 · ClinicalTrials.gov registry record · NA

Auto Control of Volume Management for Limb Loss

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT03550118: Completed NA study, sponsored by University of Washington.

NCT03550118 is a NA study that has completed, run by University of Washington. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03550118, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

The aim of this research is to create a prosthetic system that will automatically adjust the fit of the socket and create a well-fitting prosthesis for people with leg amputations who experience volume fluctuations when using their prosthesis.

Primary Outcome

Limb volume fluctuations will be measured in real-time as socket adjustment strategies are tested. This will be accomplished using a portable bioimpedance device with thin sticky electrodes that are placed on the residual limb. Specifically, the change in limb volume will be assessed from a baseline period where no socket adjustments are made to another period within the same test session where socket adjustments are made.

Interventions

  • DEVICE Adjustable socket

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2015-08-07
Est. Completion 2022-01
Phase NA
University of Washington

1,048 total trials

What the finished NCT03550118 record still lists

NCT03550118 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Adjustable socket is the first listed.

NCT03550118 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03550118 about?

NCT03550118 is a clinical study titled "Auto Control of Volume Management for Limb Loss". The aim of this research is to create a prosthetic system that will automatically adjust the fit of the socket and create a well-fitting prosthesis for people with leg amputations who experience volume fluctuations when using their prosthesis.

What is the current status of trial NCT03550118?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2015-08-07. Estimated completion is 2022-01.

What interventions are being tested in trial NCT03550118?

The interventions under investigation include: Adjustable socket (DEVICE).

Who is sponsoring clinical trial NCT03550118?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03550118's enrollment target sits among peer trials

104 836th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03550118, the US trial registry maintained by the National Library of Medicine. NCT03550118 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.